{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:59:21Z","timestamp":1760266761341},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/s11882-004-0082-5","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T16:13:51Z","timestamp":1180973631000},"page":"339-348","source":"Crossref","is-referenced-by-count":23,"title":["X-linked immunodeficiencies"],"prefix":"10.1007","volume":"4","author":[{"given":"Hans D.","family":"Ochs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"82_CR1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC: Agammaglobulinemia. Pediatrics 1952, 9:722\u2013728.","journal-title":"Pediatrics"},{"key":"82_CR2","first-page":"357","volume-title":"Immunologic Disorders in Infants and Children","author":"D Rawlings","year":"2004","unstructured":"Rawlings D: X-linked Agammaglobulinemia. In Immunologic Disorders in Infants and Children, edn 5. Edited by Stiehm ER, Ochs HD, Winkelstein JA. Philadelphia: Elsevier Saunders; 2004:357\u2013369.","edition":"edn 5"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","volume":"75","author":"HD Ochs","year":"1996","unstructured":"Ochs HD, Smith CI: X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine (Baltimore) 1996, 75:287\u2013299.","journal-title":"Medicine (Baltimore)"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","volume":"64","author":"HM Lederman","year":"1985","unstructured":"Lederman HM, Winkelstein JA: X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985, 64:145\u2013156.","journal-title":"Medicine (Baltimore)"},{"key":"82_CR5","first-page":"31","volume":"86","author":"RA Hermaszewski","year":"1993","unstructured":"Hermaszewski RA, Webster AD: Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993, 86:31\u201342.","journal-title":"Q J Med"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2141.2001.02905.x","volume":"114","author":"T Futatani","year":"2001","unstructured":"Futatani T, Watanabe C, Baba Y, et al.: Bruton\u2019s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001, 114:141\u2013149.","journal-title":"Br J Haematol"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/nar\/26.1.242","volume":"26","author":"M Vihinen","year":"1998","unstructured":"Vihinen M, Brandau O, Branden LJ, et al.: BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 1998, 26:242\u2013247.","journal-title":"Nucleic Acids Res"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(95)90346-1","volume":"345","author":"A Gardulf","year":"1995","unstructured":"Gardulf A, Andersen V, Bjorkander J, et al.: Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995, 345:365\u2013369.","journal-title":"Lancet"},{"key":"82_CR9","doi-asserted-by":"crossref","unstructured":"Yu PW, Tabuchi RS, Kato RM, et al..: Sustained correction of B cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviralmediated gene transfer. Blood 2004, In press. Using the XID model, these authors provide proof of the principle that gene therapy selectively reconstitutes the B-cell defect in XLA.","DOI":"10.1182\/blood-2003-09-3044"},{"key":"82_CR10","first-page":"447","volume-title":"Immunologic Disorders in Infants and Children","author":"A Fischer","year":"2004","unstructured":"Fischer A, Notarangelo L: Combined immunodeficiencies. In Immunologic Disorders in Infants and Children, edn 5. Edited by Stiehm ER, Ochs HD, Winkelstein JA. Philadelphia: Elsevier Saunders; 2004:447\u2013479.","edition":"edn 5"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","volume":"73","author":"M Noguchi","year":"1993","unstructured":"Noguchi M, Yi H, Rosenblatt HM, et al.: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147\u2013157.","journal-title":"Cell"},{"key":"82_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-5699(98)01391-7","volume":"20","author":"TR Malek","year":"1999","unstructured":"Malek TR, Porter BO, He YW: Multiple gamma c-dependent cytokines regulate T-cell development. Immunol Today 1999, 20:71\u201376.","journal-title":"Immunol Today"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0952-7915(00)00122-9","volume":"12","author":"A Puel","year":"2000","unstructured":"Puel A, Leonard WJ: Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease. Curr Opin Immunol 2000, 12:468\u2013473.","journal-title":"Curr Opin Immunol"},{"key":"82_CR14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","volume":"9","author":"JP Lodolce","year":"1998","unstructured":"Lodolce JP, Boone DL, Chai S, et al.: IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998, 9:669\u2013676.","journal-title":"Immunity"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2003.09.002","volume":"110","author":"LP Hale","year":"2004","unstructured":"Hale LP, Buckley RH, Puck JM, Patel DD: Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency. Clin Immunol 2004, 110:63\u201370.","journal-title":"Clin Immunol"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0167-5699(96)80903-0","volume":"17","author":"JM Puck","year":"1996","unstructured":"Puck JM: IL2RGbase: a database of gamma c-chain defects causing human X-SCID. Immunol Today 1996, 17:507\u2013511.","journal-title":"Immunol Today"},{"key":"82_CR17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/humu.9235","volume":"23","author":"SL Ginn","year":"2004","unstructured":"Ginn SL, Smyth C, Wong M, et al.: A novel splice-site mutation in the common gamma chain (gamma c) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype. Hum Mutat 2004, 23:522\u2013523.","journal-title":"Hum Mutat"},{"key":"82_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1073\/pnas.97.1.274","volume":"97","author":"P Bousso","year":"2000","unstructured":"Bousso P, Wahn V, Douagi I, et al.: Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. Proc Natl Acad Sci U S A 2000, 97:274\u2013278.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","volume":"2","author":"RA Gatti","year":"1968","unstructured":"Gatti RA, Meuwissen HJ, Allen HD, et al.: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968, 2:1366\u20131369.","journal-title":"Lancet"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.immunol.22.012703.104614","volume":"22","author":"RH Buckley","year":"2004","unstructured":"Buckley RH: Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004, 22:625\u2013655.","journal-title":"Annu Rev Immunol"},{"key":"82_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","volume":"361","author":"C Antoine","year":"2003","unstructured":"Antoine C, Muller S, Cant A, et al.: Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u201399. Lancet 2003, 361:553\u2013560.","journal-title":"Lancet"},{"key":"82_CR22","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood.V92.11.4090","volume":"92","author":"S Hacein-Bey","year":"1998","unstructured":"Hacein-Bey S, Basile GD, Lemerle J, et al.: gamma c gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T-cell differentiation from gammac(-) X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures. Blood 1998, 92:4090\u20134097.","journal-title":"Blood"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V95.10.3071","volume":"95","author":"C Soudais","year":"2000","unstructured":"Soudais C, Shiho T, Sharara LI, et al.: Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer. Blood 2000, 95:3071\u20133077.","journal-title":"Blood"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","volume":"288","author":"M Cavazzana-Calvo","year":"2000","unstructured":"Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al.:Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669\u2013672.","journal-title":"Science"},{"key":"82_CR25","doi-asserted-by":"crossref","unstructured":"Hacein-Bey S, LeDeist F, Carlier F: Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002, 1185\u20131193. Report of the first successful gene therapy in humans.","DOI":"10.1056\/NEJMoa012616"},{"key":"82_CR26","doi-asserted-by":"crossref","unstructured":"Hacein-Bey S, von Kalle C, Schmidt M, et al.: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 415\u2013419.","DOI":"10.1126\/science.1088547"},{"key":"82_CR27","first-page":"380","volume-title":"Immunologic Disorders in Infants and Children","author":"L Notarangelo","year":"2004","unstructured":"Notarangelo L, Durandy A: X-linked hyper-IgM syndrome type 1 due to CD40 ligand deficiency (HIGM1). In Immunologic Disorders in Infants and Children, edn 5. Edited by Stiehm ER, Ochs HD, Winkelstein JA. Philadelphia: Elsevier Saunders; 2004:380\u2013384.","edition":"edn 5"},{"key":"82_CR28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","volume":"9","author":"C Kooten van","year":"1997","unstructured":"van Kooten C, Banchereau J: Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 1997, 9:330\u2013337.","journal-title":"Curr Opin Immunol"},{"key":"82_CR29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.178.3.1097","volume":"178","author":"S Nonoyama","year":"1993","unstructured":"Nonoyama S, Hollenbaugh D, Aruffo A, et al.: B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993, 178:1097\u20131102.","journal-title":"J Exp Med"},{"key":"82_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy J, Espanol-Boren T, Thomas C, et al.: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997, 131:47\u201354.","journal-title":"J Pediatr"},{"key":"82_CR31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","volume":"82","author":"JA Winkelstein","year":"2003","unstructured":"Winkelstein JA, Marino MC, Ochs H, et al.: The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003, 82:373\u2013384. A comprehensive report from the National XHIG Registry.","journal-title":"Medicine (Baltimore)"},{"key":"82_CR32","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","volume":"92","author":"K Seyama","year":"1998","unstructured":"Seyama K, Nonoyama S, Gangsaas I, et al.: Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998, 92:2421\u20132434.","journal-title":"Blood"},{"key":"82_CR33","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1073\/pnas.91.6.2110","volume":"91","author":"A Villa","year":"1994","unstructured":"Villa A, Notarangelo LD, Di Santo JP, et al.: Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci U S A 1994, 91:2110\u20132114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"82_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajh.20044","volume":"76","author":"D Tomizawa","year":"2004","unstructured":"Tomizawa D, Imai K, Ito S, et al.: Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience. Am J Hematol 2004, 76:33\u201339.","journal-title":"Am J Hematol"},{"key":"82_CR35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2003-06-2014","volume":"103","author":"AR Gennery","year":"2004","unstructured":"Gennery AR, Khawaja K, Veys P, et al.: Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993\u20132002. Blood 2004, 103:1152\u20131157.","journal-title":"Blood"},{"key":"82_CR36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/adc.62.10.989","volume":"62","author":"A Clarke","year":"1987","unstructured":"Clarke A, Phillips DI, Brown R, Harper PS: Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child 1987, 62:989\u2013996.","journal-title":"Arch Dis Child"},{"key":"82_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF02075774","volume":"155","author":"M Abinun","year":"1996","unstructured":"Abinun M, Spickett G, Appleton AL, et al.: Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr 1996, 155:146\u2013147.","journal-title":"Eur J Pediatr"},{"key":"82_CR38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-2008-1043834","volume":"211","author":"P Schweizer","year":"1999","unstructured":"Schweizer P, Kalhoff H, Horneff G, et al.: [Polysaccharide specific humoral immunodeficiency in ectodermal dysplasia: case report of a boy with two affected brothers]. Klin Padiatr 1999, 211:459\u2013461.","journal-title":"Klin Padiatr"},{"key":"82_CR39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/adc.88.4.340","volume":"88","author":"ED Carrol","year":"2003","unstructured":"Carrol ED, Gennery AR, Flood TJ, et al.: Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch Dis Child 2003, 88:340\u2013341.","journal-title":"Arch Dis Child"},{"key":"82_CR40","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/316914","volume":"67","author":"J Zonana","year":"2000","unstructured":"Zonana J, Elder ME, Schneider LC, et al.: A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000, 67:1555\u20131562.","journal-title":"Am J Hum Genet"},{"key":"82_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","volume":"27","author":"R Doffinger","year":"2001","unstructured":"Doffinger R, Smahi A, Bessia C, et al.: X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001, 27:277\u2013285.","journal-title":"Nat Genet"},{"key":"82_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","volume":"2","author":"A Jain","year":"2001","unstructured":"Jain A, Ma CA, Liu S, et al.: Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001, 2:223\u2013228.","journal-title":"Nat Immunol"},{"key":"82_CR43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1172\/JCI19960","volume":"112","author":"JS Orange","year":"2003","unstructured":"Orange JS, Geha RS: Finding NEMO: genetic disorders of NF-[kappa]B activation. J Clin Invest 2003, 112:983\u2013985. This is a straight-forward review of NF-kB signaling and its regulation.","journal-title":"J Clin Invest"},{"key":"82_CR44","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/hmg\/10.19.2171","volume":"10","author":"S Aradhya","year":"2001","unstructured":"Aradhya S, Woffendin H, Jakins T, et al.: A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 2001, 10:2171\u20132179.","journal-title":"Hum Mol Genet"},{"key":"82_CR45","first-page":"516","volume-title":"Immunologic Disorders in Infants and Children","author":"J Sullivan","year":"2004","unstructured":"Sullivan J: X-linked lymphoproliferative syndrome. In Immunologic Disorders in Infants and Children, edn 5. Edited by Stiehm ER, Ochs HD, Winkelstein JA. Philadelphia: Elsevier Saunders; 2004:516\u2013520.","edition":"edn 5"},{"key":"82_CR46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1202","volume":"3","author":"P Engel","year":"2003","unstructured":"Engel P, Eck MJ, Terhorst C: The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 2003, 3:813\u2013821. A detailed review of the molecular background of XLP.","journal-title":"Nat Rev Immunol"},{"key":"82_CR47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1600-065X.2003.00023.x","volume":"192","author":"S Latour","year":"2003","unstructured":"Latour S, Veillette A: Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol Rev 2003, 192:212\u2013224.","journal-title":"Immunol Rev"},{"key":"82_CR48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/intimm\/dxh074","volume":"16","author":"M Simarro","year":"2004","unstructured":"Simarro M, Lanyi A, Howie D, et al.: SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9. Int Immunol 2004, 16:727\u2013736.","journal-title":"Int Immunol"},{"key":"82_CR49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/90615","volume":"2","author":"S Latour","year":"2001","unstructured":"Latour S, Gish G, Helgason CD, et al.: Regulation of SLAMmediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol 2001, 2:681\u2013690.","journal-title":"Nat Immunol"},{"key":"82_CR50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/87713","volume":"2","author":"C Wu","year":"2001","unstructured":"Wu C, Nguyen KB, Pien GC, et al.: SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol 2001, 2:410\u2013414.","journal-title":"Nat Immunol"},{"key":"82_CR51","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1073\/pnas.131193098","volume":"98","author":"MJ Czar","year":"2001","unstructured":"Czar MJ, Kersh EN, Mijares LA, et al.: Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/ SAP. Proc Natl Acad Sci U S A 2001, 98:7449\u20137454.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"82_CR52","doi-asserted-by":"crossref","first-page":"18662","DOI":"10.1074\/jbc.M312313200","volume":"279","author":"PA Valdez","year":"2004","unstructured":"Valdez PA, Wang H, Seshasayee D, et al.: NTB-A, a new activating receptor in T cells that regulates autoimmune disease. J Biol Chem 2004, 279:18662\u201318669.","journal-title":"J Biol Chem"},{"key":"82_CR53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","volume":"192","author":"S Parolini","year":"2000","unstructured":"Parolini S, Bottino C, Falco M, et al.: X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000, 192:337\u2013346.","journal-title":"J Exp Med"},{"key":"82_CR54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.194.3.235","volume":"194","author":"C Bottino","year":"2001","unstructured":"Bottino C, Falco M, Parolini S, et al.: NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 2001, 194:235\u2013246.","journal-title":"J Exp Med"},{"key":"82_CR55","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2003-09-3359","volume":"103","author":"R Sharifi","year":"2004","unstructured":"Sharifi R, Sinclair JC, Gilmour KC, et al.: SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 2004, 103:3821\u20133827.","journal-title":"Blood"},{"key":"82_CR56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jmv.10504","volume":"71","author":"L Yin","year":"2003","unstructured":"Yin L, Al-Alem U, Liang J, et al.: Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypogammaglobulinemia. J Med Virol 2003, 71:446\u2013455.","journal-title":"J Med Virol"},{"key":"82_CR57","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature01318","volume":"421","author":"S Crotty","year":"2003","unstructured":"Crotty S, Kersh EN, Cannons J, et al.: SAP is required for generating long-term humoral immunity. Nature 2003, 421:282\u2013287.","journal-title":"Nature"},{"key":"82_CR58","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood-2003-07-2525","volume":"103","author":"A Malbran","year":"2004","unstructured":"Malbran A, Belmonte L, Ruibal-Ares B, et al.: Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 2004, 103:1625\u20131631.","journal-title":"Blood"},{"key":"82_CR59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/14737159.3.5.549","volume":"3","author":"KC Gilmour","year":"2003","unstructured":"Gilmour KC, Gaspar HB: Pathogenesis and diagnosis of X-linked lymphoproliferative disease. Expert Rev Mol Diagn 2003, 3:549\u2013561.","journal-title":"Expert Rev Mol Diagn"},{"key":"82_CR60","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.V98.5.1321","volume":"98","author":"M Morra","year":"2001","unstructured":"Morra M, Silander O, Calpe S, et al.: Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 2001, 98:1321\u20131325.","journal-title":"Blood"},{"key":"82_CR61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","volume":"38","author":"TA Seemayer","year":"1995","unstructured":"Seemayer TA, Gross TG, Egeler RM, et al.: X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995, 38:471\u2013478.","journal-title":"Pediatr Res"},{"key":"82_CR62","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1067\/mpd.2001.112511","volume":"138","author":"UH Ziegner","year":"2001","unstructured":"Ziegner UH, Ochs HD, Schanen C, et al.: Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr 2001, 138:570\u2013573.","journal-title":"J Pediatr"},{"key":"82_CR63","doi-asserted-by":"crossref","first-page":"29593","DOI":"10.1074\/jbc.M300565200","volume":"278","author":"S Sanzone","year":"2003","unstructured":"Sanzone S, Zeyda M, Saemann MD, et al.: SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from Xlinked lymphoproliferative disease patients. J Biol Chem 2003, 278:29593\u201329599.","journal-title":"J Biol Chem"},{"key":"82_CR64","first-page":"505","volume-title":"Immunologic Disorders in Infants and Children","author":"H Ochs","year":"2004","unstructured":"Ochs H, Nelson D, Stiehm E: Other well-definied immunodeficiency syndromes. In Immunologic Disorders in Infants and Children, edn 5. Edited by Stiehm ER, Ochs HD, Winkelstein JA. Philadelphia: Elsevier Saunders; 2004:505\u2013516.","edition":"edn 5"},{"key":"82_CR65","first-page":"922","volume":"79","author":"JM Derry","year":"1994","unstructured":"Derry JM, Ochs HD, Francke U: Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994, 79:following 922.","journal-title":"Cell"},{"key":"82_CR66","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ng0495-414","volume":"9","author":"A Villa","year":"1995","unstructured":"Villa A, Notarangelo L, Macchi P, et al.: X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 1995, 9:414\u2013417.","journal-title":"Nat Genet"},{"key":"82_CR67","first-page":"379","volume":"4","author":"HD Ochs","year":"2002","unstructured":"Ochs HD: The Wiskott-Aldrich syndrome. Isr Med Assoc J 2002, 4:379\u2013384.","journal-title":"Isr Med Assoc J"},{"key":"82_CR68","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V85.9.2471.bloodjournal8592471","volume":"85","author":"G Wengler","year":"1995","unstructured":"Wengler G, Gorlin JB, Williamson JM, et al.: Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 1995, 85:2471\u20132477.","journal-title":"Blood"},{"key":"82_CR69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri884","volume":"2","author":"AJ Thrasher","year":"2002","unstructured":"Thrasher AJ: WASP in immune-system organization and function. Nat Rev Immunol 2002, 2:635\u2013646.","journal-title":"Nat Rev Immunol"},{"key":"82_CR70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0952-7915(03)00112-2","volume":"15","author":"LD Notarangelo","year":"2003","unstructured":"Notarangelo LD, Ochs HD: Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. Curr Opin Immunol 2003, 15:585\u2013591.","journal-title":"Curr Opin Immunol"},{"key":"82_CR71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.0818-9641.2002.01147.x","volume":"81","author":"S Linder","year":"2003","unstructured":"Linder S, Wintergerst U, Bender-Gotze C, et al.: Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype. Immunol Cell Biol 2003, 81:130\u2013136.","journal-title":"Immunol Cell Biol"},{"key":"82_CR72","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/35074551","volume":"3","author":"N Martinez-Quiles","year":"2001","unstructured":"Martinez-Quiles N, Rohatgi R, Anton IM, et al.: WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat Cell Biol 2001, 3:484\u2013491.","journal-title":"Nat Cell Biol"},{"key":"82_CR73","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1097-2765(02)00728-1","volume":"10","author":"Y Sasahara","year":"2002","unstructured":"Sasahara Y, Rachid R, Byrne MJ, et al.: Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell 2002, 10:1269\u20131281.","journal-title":"Mol Cell"},{"key":"82_CR74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/35004513","volume":"404","author":"AS Kim","year":"2000","unstructured":"Kim AS, Kakalis LT, Abdul-Manan N, et al.: Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 2000, 404:151\u2013158.","journal-title":"Nature"},{"key":"82_CR75","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","volume":"27","author":"K Devriendt","year":"2001","unstructured":"Devriendt K, Kim AS, Mathijs G, et al.: Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001, 27:313\u2013317.","journal-title":"Nat Genet"},{"key":"82_CR76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood.V95.4.1283.004k44_1283_1292","volume":"95","author":"R Rengan","year":"2000","unstructured":"Rengan R, Ochs HD, Sweet LI, et al.: Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood 2000, 95:1283\u20131292.","journal-title":"Blood"},{"key":"82_CR77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V55.2.243.243","volume":"55","author":"HD Ochs","year":"1980","unstructured":"Ochs HD, Slichter SJ, Harker LA, et al.: The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 1980, 55:243\u2013252.","journal-title":"Blood"},{"key":"82_CR78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00360-6","volume":"17","author":"L Dupre","year":"2002","unstructured":"Dupre L, Aiuti A, Trifari S, et al.: Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 2002, 17:157\u2013166.","journal-title":"Immunity"},{"key":"82_CR79","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai K, Morio T, Zhu Y, et al.: Clinical course of patients with WASP gene mutations. Blood 2004, 103:456\u2013464. This longitudinal study of a cohort of WAS patients demonstrates a close correlation between genotype and clinical outcome.","journal-title":"Blood"},{"key":"82_CR80","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","volume":"97","author":"AH Filipovich","year":"2001","unstructured":"Filipovich AH, Stone JV, Tomany SC, et al.: Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001, 97:1598\u20131603.","journal-title":"Blood"},{"key":"82_CR81","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2002-05-1423","volume":"101","author":"C Klein","year":"2003","unstructured":"Klein C, Nguyen D, Liu CH, et al.: Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 2003, 101:2159\u20132166.","journal-title":"Blood"},{"key":"82_CR82","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2002-11-3489","volume":"102","author":"TS Strom","year":"2003","unstructured":"Strom TS, Turner SJ, Andreansky S, et al.: Defects in T-cellmediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vectormediated gene transfer into repopulating hematopoietic cells. Blood 2003, 102:3108\u20133116.","journal-title":"Blood"},{"key":"82_CR83","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/104303402753812449","volume":"13","author":"T Wada","year":"2002","unstructured":"Wada T, Jagadeesh GJ, Nelson DL, Candotti F: Retrovirusmediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. Hum Gene Ther 2002, 13:1039\u20131046.","journal-title":"Hum Gene Ther"},{"key":"82_CR84","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.166.8.5245","volume":"166","author":"T Ariga","year":"2001","unstructured":"Ariga T, Kondoh T, Yamaguchi K, et al.: Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol 2001, 166:5245\u20135249.","journal-title":"J Immunol"},{"key":"82_CR85","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1073\/pnas.151260498","volume":"98","author":"T Wada","year":"2001","unstructured":"Wada T, Schurman SH, Otsu M, et al.: Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A 2001, 98:8697\u20138702.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"82_CR86","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","volume":"100","author":"BR Powell","year":"1982","unstructured":"Powell BR, Buist NR, Stenzel P: An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982, 100:731\u2013737.","journal-title":"J Pediatr"},{"key":"82_CR87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","volume":"39","author":"RS Wildin","year":"2002","unstructured":"Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537\u2013545.","journal-title":"J Med Genet"},{"key":"82_CR88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3476(05)80140-4","volume":"117","author":"EG Seidman","year":"1990","unstructured":"Seidman EG, Lacaille F, Russo P, et al.: Successful treatment of autoimmune enteropathy with cyclosporine. J Pediatr 1990, 117:929\u2013932.","journal-title":"J Pediatr"},{"key":"82_CR89","doi-asserted-by":"crossref","unstructured":"Russell W, Russell L, Gower J: Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the X\/O sex-chromosome constitution is female. Proc Natl Acad Sci U S A 1959, 554\u2013560.","DOI":"10.1073\/pnas.45.4.554"},{"key":"82_CR90","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY: FOXP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330\u2013336.","journal-title":"Nat Immunol"},{"key":"82_CR91","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057\u20131061. This study demonstrates the importance of FOXP3 in the generation of regulatory T cells.","journal-title":"Science"},{"key":"82_CR92","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337\u2013342.","journal-title":"Nat Immunol"},{"key":"82_CR93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1026","volume":"3","author":"JF Bach","year":"2003","unstructured":"Bach JF: Regulatory T cells under scrutiny. Nat Rev Immunol 2003, 3:189\u2013198.","journal-title":"Nat Rev Immunol"},{"key":"82_CR94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","volume":"27","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Jeffery EW, Hjerrild KA, et al.: Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68\u201373.","journal-title":"Nat Genet"},{"key":"82_CR95","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"TA Chatila","year":"2000","unstructured":"Chatila TA, Blaeser F, Ho N, et al.: JM2, encoding a fork headrelated protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000, 106:R75-R81.","journal-title":"J Clin Invest"},{"key":"82_CR96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s002510100358","volume":"53","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Brunkow ME, Ramsdell F, et al.: A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA->AAUGAA) leads to the IPEX syndrome. Immunogenetics 2001, 53:435\u2013439.","journal-title":"Immunogenetics"},{"key":"82_CR97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin RS, Ramsdell F, Peake J, et al.: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18\u201320.","journal-title":"Nat Genet"},{"key":"82_CR98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","volume":"15","author":"E Gambineri","year":"2003","unstructured":"Gambineri E, Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003, 15:430\u2013435.","journal-title":"Curr Opin Rheumatol"},{"key":"82_CR99","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, et al.: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20\u201321.","journal-title":"Nat Genet"},{"key":"82_CR100","doi-asserted-by":"crossref","unstructured":"DiRocco M, Marta R: X linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch Dis Child Fetal Neonatal Ed 1996:F144.","DOI":"10.1136\/fn.75.2.F144"},{"key":"82_CR101","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJM200106073442304","volume":"344","author":"O Baud","year":"2001","unstructured":"Baud O, Goulet O, Canioni D, et al.: Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001, 344:1758\u20131762.","journal-title":"N Engl J Med"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0082-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-004-0082-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0082-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T05:00:05Z","timestamp":1683867605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-004-0082-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s11882-004-0082-5","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}